These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6292885)

  • 21. Neonatal estrogen exposure induces lobe-specific alterations in adult rat prostate androgen receptor expression.
    Prins GS
    Endocrinology; 1992 Jun; 130(6):3703-14. PubMed ID: 1597166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neonatal estrogen exposure induces lobe-specific alterations in adult rat prostate androgen receptor expression.
    Prins GS
    Endocrinology; 1992 Apr; 130(4):2401-12. PubMed ID: 1547747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of prolactin binding sites in vitro by membrane fluidizers. IV. Differential effects on plasma membrane and Golgi fractions of male prostate and female liver in the rat.
    Dave JR; Witorsch RJ
    Biochem Biophys Res Commun; 1986 Feb; 134(3):1122-8. PubMed ID: 3004484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional expression of transforming growth factor-alpha in rat ventral prostate during postnatal development, after androgen ablation, and after androgen replacement.
    Banerjee S; Banerjee PP; Zirkin BR; Brown TR
    Endocrinology; 1998 Jun; 139(6):3005-13. PubMed ID: 9607812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteins of the rat prostate. II. Synthesis of new proteins in the ventral lobe during castration-induced regression.
    Lee C; Sensibar JA
    J Urol; 1987 Oct; 138(4):903-8. PubMed ID: 3656552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycosaminoglycans in the three lobes of the rat prostate following castration and testosterone treatment.
    Terry DE; Clark AF
    Biochem Cell Biol; 1996; 74(5):653-8. PubMed ID: 9018372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a cellular receptor for transforming growth factor-beta in rat ventral prostate and its negative regulation by androgens.
    Kyprianou N; Isaacs JT
    Endocrinology; 1988 Oct; 123(4):2124-31. PubMed ID: 2901342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of prolactin binding sites in vitro by membrane fluidizers. II. Age-dependent effects on rat ventral prostatic membranes.
    Dave JR; Witorsch RJ
    Biochim Biophys Acta; 1984 May; 772(3):321-7. PubMed ID: 6326828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific prolactin binding sites in the prostate and testis of rats.
    Aragona C; Friesen HG
    Endocrinology; 1975 Sep; 97(3):677-84. PubMed ID: 170071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of aging and castration on plasminogen activator and metalloprotease activities in the rat prostate complex.
    Wilson MJ; Norris H; Woodson M; Sinha AA; Estensen RD
    Cell Mol Biol Res; 1995; 41(6):603-12. PubMed ID: 8777440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic action of prolactin in regressing prostate: independent of androgen action.
    Smith C; Assimos D; Lee C; Grayhack JT
    Prostate; 1985; 6(1):49-59. PubMed ID: 3969372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen-insensitive prostate cancer cells transiently respond to castration treatment when growing in an androgen-dependent prostate environment.
    Halin S; Hammarsten P; Wikström P; Bergh A
    Prostate; 2007 Mar; 67(4):370-7. PubMed ID: 17192959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of castration, testosterone, estradiol, and prolactin on specific prolactin-binding activity in ventral prostate of male rats.
    Kledzik GS; Marshall S; Campbell GA; Gelato M; Meites J
    Endocrinology; 1976 Feb; 98(2):373-9. PubMed ID: 946169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of prolactin binding sites in vitro by membrane fluidizers. I. Effects on adult rat ventral prostatic membranes.
    Dave JR; Witorsch RJ
    Biochem Biophys Res Commun; 1983 May; 113(1):220-8. PubMed ID: 6305349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Action of prolactin in regressing prostate: independent of action mediated by androgen receptors.
    Assimos D; Smith C; Lee C; Grayhack JT
    Prostate; 1984; 5(6):589-95. PubMed ID: 6494057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death.
    Kyprianou N; Isaacs JT
    Mol Endocrinol; 1989 Oct; 3(10):1515-22. PubMed ID: 2608047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and localization of transforming growth factor-beta receptors type I and type II in the rat ventral prostate during regression.
    Kim IY; Ahn HJ; Zelner DJ; Park L; Sensibar JA; Lee C
    Mol Endocrinol; 1996 Jan; 10(1):107-15. PubMed ID: 8838150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5 alpha-reductase inhibitor finasteride.
    Rittmaster RS; Manning AP; Wright AS; Thomas LN; Whitefield S; Norman RW; Lazier CB; Rowden G
    Endocrinology; 1995 Feb; 136(2):741-8. PubMed ID: 7835306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incorporation and release of tritiated leucine in rat prostate during castration induced involution.
    Bockrath JM; Lee C; Grayhack JT
    Invest Urol; 1981 Nov; 19(3):169-75. PubMed ID: 7298286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen.
    Prins GS; Birch L
    Endocrinology; 1995 Mar; 136(3):1303-14. PubMed ID: 7867585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.